Health Stock Hits 52-Week High: CVS Could Rally Further
CVS Health recently touched a fresh 52-week high after strong Q1 results. This deep dive explains why the rally may c...
Learn reliable sources and practical steps to access dividend ETF expense ratios, plus tips on reading fee disclosures.
11,990 articlesCVS Health recently touched a fresh 52-week high after strong Q1 results. This deep dive explains why the rally may c...
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...
Chevron reported a year-over-year drop in earnings, even as production rose. This article breaks down why, what it me...
IBP's Q1 2026 results set the tone for the year. This original analysis breaks down the numbers, margins, and guidanc...
A monthly dividend growth fund has outperformed SCHD by 38 percentage points over the past decade, challenging the tr...
A Federal Reserve governor's message carries big weight for markets. This piece breaks down the implications of words...
Lincoln Financial is positioned as a stable anchor for retirement, while three Miller-style bets—Strategy, Nabors, an...
Six months into 2026, Ford faces a rare stumble as a Japanese competitor outsells its flagship F-Series in the period...
Apple’s board approved a fresh $100 billion buyback as Q2 2026 results beat expectations, underscoring the tech giant...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
Worried about the stock market as 2026 unfolds? This guide offers a clear, practical plan to manage risk, diversify, ...